Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 09 - 13 tags : Ongoing save search
Galecto Announces First Patient Treated in Phase 2 Trial of Oral Galectin-3 Inhibitor GB1211 in Liver CirrhosisGalecto now has three ongoing Phase 2 clinical trials with three different drug candidates in three high value indications
Published: 2021-09-13 (Crawled : 18:00) - biospace.com/
GLTO | $0.6501 -7.21% -7.77% 76K
|
Health Technology
|
| O: 0.0%
H: 2.27%
C: -2.27%
gb1211 phase 2 ongoing clinical trials cirrhosis trials drug liver trial liver cirrhosis galectin-3
RedHill Biopharma Accelerates Ongoing U.S. Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients with South African Approval
Published: 2021-09-13 (Crawled : 12:00) - biospace.com/
RDHL | $0.415 -2.99% -3.08% 190K
|
Health Technology
|
| O: -0.74%
H: 0.45%
C: -7.98%
covid phase 2 biopharma ongoing phase 2/3 approval
Matinas BioPharma Announces Positive Data in the Ongoing EnACT Trial of MAT2203 (Oral Amphotericin B) for the Treatment of Cryptococcal Meningitis, Exceeding the Prespecified Primary Endpoint Threshold
Published: 2021-09-13 (Crawled : 11:00) - globenewswire.com
MTNB | $0.1818 0.17% 0.0% 520K
|
Health Technology
|
| O: 7.75%
H: 23.6%
C: 17.98%
treatment biopharma ongoing positive trial mat2203
TCR2 Therapeutics to Announce Extended Results from Ongoing Phase 1/2 Trial of Gavo-cel in Mesothelin-Expressing Solid Tumors
Published: 2021-09-13 (Crawled : 11:00) - globenewswire.com
TCRR 4 | $1.48 3.38% 3.9M
|
Health Technology
|
| O: 1.71%
H: 3.42%
C: -0.27%
solid tumors ongoing phase 1 results trial phase 2 phase 3 cel
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.